Traitement médical des hémangiomes immatures
(2006) Annales de Chirurgie Plastique Esthetique — Vol. 51, n° 4-5, p. 310-320 (2006)
Files
pdfdocument.pdf
Restricted Access - Adobe PDF
- 939.26 KB
Details
- Authors
- Abstract
- Infantile hemangioma always involute in 5 to 7 years. However, 10% of proliferating hemangiomas will necessitate a therapeutic approach, often medical, in order to avoid life or organ threatening, fonctional or esthetic sequelae. "Which hemangioma need to be treated, when and how" are important questions for the optimal management of infantile hemangiomas. Corticotherapy is still the treatment of choice for these lesions. Other anti-angiogenic molecules have also been successfully used such as interferon alfa-2a and vincristine. This chapter tries to answer these questions and detail the different medical modalities for the treatment of infantile hemangioma. © 2006 Elsevier Masson SAS. All rights reserved.
- Affiliations
Citations
Boon, L., Bataille, A.-C., Bernier, V., Vermylen, C., & Verellen, G. (2006). Traitement médical des hémangiomes immatures. Annales de Chirurgie Plastique Esthetique, 51(4-5), 310-320. https://doi.org/10.1016/j.anplas.2006.07.004 (Original work published 2006)